Context Therapeutics Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-12-31
|
-0.28
|
0.00
|
0.28
|
100.00%
|
|
2022-09-30
|
-0.25
|
-0.24
|
0.01
|
4.00%
|
|
2022-06-30
|
-0.25
|
-0.25
|
0.00
|
0.00%
|
|
2022-03-31
|
-0.24
|
-0.22
|
0.02
|
8.33%
|
|
2021-12-31
|
-0.27
|
-0.58
|
-0.31
|
-114.81%
|
|
2021-09-30
|
0.00
|
-0.46
|
-0.46
|
0.00%
|
|
2021-06-30
|
0.00
|
0.97
|
0.97
|
0.00%
|
|
2018-09-30
|
0.00
|
-0.88
|
-0.88
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.71
|
|
2021-12-31
|
-0.95
|